Stability data play a critical role in product development, helping sponsors evaluate how product quality attributes change over time under defined storage, handling, and transportation conditions. These studies support the establishment of storage conditions, retest periods, and shelf-life claims while providing important evidence for regulatory submissions.
Esco Aster supports stability and
analytical testing programs for a range of biopharmaceutical products and
emerging therapeutic modalities. With experience in exosomes and stem
cell-related products, our capabilities can be adapted to support additional
biologic and biopharmaceutical products through customized analytical and
stability testing strategies, including client-transferred methods where
appropriate. Stability studies are designed in accordance with applicable ICH
Q1A(R2) Stability Testing Guidelines and regulatory expectations, with study
parameters tailored to the specific characteristics and development stage of
each product.
By integrating stability testing with our
Process Development, CMC Development, Analytical Development, and Clinical
Manufacturing capabilities, Esco Aster offers a coordinated approach to
generating stability data throughout the product development lifecycle, from
early-stage development and IND-enabling activities through clinical programs
and beyond.
Stability testing is performed to evaluate
how the critical quality attributes (CQAs) of a drug substance or drug product
may change over time when exposed to environmental and physical factors such as
temperature, humidity, light, and mechanical stress.
These studies are designed to support the
determination of appropriate retest periods for drug substances and shelf-life
claims for drug products within their intended container-closure systems and
recommended storage conditions.
At Esco Aster, stability programs are developed collaboratively with sponsors to define:
Each stability strategy is customized to align with product-specific requirements and development goals.

Real-time stability studies involve storing
materials under their intended storage conditions and monitoring critical
quality attributes at predefined intervals over time.
These studies provide direct evidence of
product stability and may be used to support:
Accelerated stability studies evaluate
product performance under elevated stress conditions, such as increased
temperature and humidity, to assess potential degradation pathways within a
shorter timeframe.
The resulting data may help sponsors:
For clinical trial materials and commercial drug products, long-term studies are typically conducted under intended storage conditions, while shorter-duration studies at elevated temperatures may be incorporated to support product distribution and handling considerations.

Generating meaningful stability data requires more than sample storage alone. Stability-indicating analytical testing is performed at predefined study intervals to assess product quality throughout the study period.
Depending on the product and study objectives, analytical assessments may include:
These analytical methods are frequently developed, optimized, qualified, and validated by Esco Aster as part of our integrated analytical development services, enabling consistency between development, testing, and manufacturing activities.

Whether you are developing a cell therapy
product, viral vector, plasmid DNA platform, exosome-based therapy, or biologic
drug product, Esco Aster can work with your team to design a stability program
aligned with your product requirements and development objectives.
Contact us to discuss your stability
testing needs and explore a study design tailored to your program!